CombiMatrix Molecular Diagnostics, Array Genomics to Co-Develop CGH Diagnostics | GenomeWeb

NEW YORK, March 13 (GenomeWeb News) - CombiMatrix Molecular Diagnostics, a subsidiary of Acacia Research's CombiMatrix group, said today that it has signed an agreement with Paris-based Array Genomics to co-develop and co-market a series of comparative genomic hybridization microarrays for diagnosing genetic anomalies associated with mental retardation.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.